Novo Nordisk $NVO says Wegovy is now available to eligible Medicare beneficiaries living with obesity through its Medicare GLP-1 Bridge program. Eligible patients can access Wegovy for a $50 monthly copay, with the program running through the end of 2027.
Gorilla Technology has raised its Q2 2026 revenue outlook to at least US$44 million, reflecting continued contract wins and accelerating demand for AI infrastructure.
This outlook is above current external market estimates of approximately US$33.9 million and underscores Gorilla's ability to convert signed commercial commitments into recognized revenue.
Key highlights:
โ Q2 2026 revenue outlook raised to at least US$44 million
โ More than 55% sequential growth versus Q1 2026
โ More than 100% year-over-year growth versus Q2 2025
โ Driven by strong contract execution and accelerating AI infrastructure demand
The Company hopes to provide an updated outlook for 2026 when it reports its Q2 2026 and first-half 2026 financial results.
Read the Press Release Here: https://t.co/oxsJIhRobm
#GorillaTechnology #GRRR $GRRR #AI #ArtificialIntelligence #AIInfrastructure #DataCenters #DigitalTransformation #NASDAQ #Growth
Successful launch!๐๐๐๐๐๐๐๐๐๐
All satellites were captured within minutes and already orbiting Earth with all systems nominal.
Congratulations to the incredible AST SpaceMobile team! 250Y U.S.A. ๐๐ถ ๐ค